AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
On July 25, 2025, Absci's stock experienced a significant drop of 14.81% in pre-market trading.
Absci has recently announced the pricing of a public offering of 16,670,000 shares of common stock at $3.00 per share. This move has led to a nearly 14% decline in the company's stock price in pre-market trading. The proceeds from this offering are intended to support the advancement of Absci's internal drug programs and continued development efforts.
The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $50 million. This public offering includes an additional option for $7.5 million in stock, managed by top financial institutions.

Get the scoop on pre-market movers and shakers in the US stock market.

Jan.02 2026

Jan.02 2026

Jan.02 2026

Jan.02 2026

Jan.02 2026
Daily stocks & crypto headlines, free to your inbox
Comments

No comments yet